rethinkPeptides Search
Menu
Study breakdown

Apelin Drops After Heart Attack in Humans: A New Peptide Biomarker for MI

evidence
The takeaway

Plasma apelin concentration was significantly depressed following acute MI in humans, identifying apelin as a potential new cardiac biomarker that decreases (unlike BNP which increases) during heart attack.

Key finding

Plasma apelin concentration was significantly depressed following acute MI in humans, identifying apelin as a potential new cardiac biomarker that dec

What the researchers found

Plasma apelin concentration was significantly depressed following acute MI in humans, identifying apelin as a potential new cardiac biomarker that decreases (unlike BNP which increases) during heart attack.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Apelin Drops After Heart Attack in Humans: A New Peptide Biomarker for MI
What was found?
Plasma apelin concentration was significantly depressed following acute MI in humans, identifying apelin as a potential new cardiac biomarker that decreases (unlike BNP which increases) during heart attack.

Read the original research

Plasma apelin concentration is depressed following acute myocardial infarction in man.

European journal of heart failure, 11(6), 551-8

Citation

Weir, Robin A P; Chong, Kwok Shiong; Dalzell, Jonathan R; Petrie, Colin J; Murphy, Charles A; Steedman, Tracey; Mark, Patrick B; McDonagh, Theresa A; Dargie, Henry J; McMurray, John J V. (2009). Plasma apelin concentration is depressed following acute myocardial infarction in man.. European journal of heart failure, 11(6), 551-8. https://doi.org/10.1093/eurjhf/hfp043